Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients

Journal of Medical Virology

Volumn 79, Issue 4, 2007, Pages 401-407

  Correa, Rita Mariel ^a,g   Fellner, María Dolores ^a   Durand, Karina ^a   Redini, Liliana ^d   Alonio, Virginia ^a   Yampolsky, Claudio ^c,d   Colobraro, Antonio ^f   Sevlever, Gustavo ^e,f   Teyssié, Angélica ^a   Benetucci, Jorge ^b   Picconi, María Alejandra ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b Lab de Retrovirus y Virus Asociados   (Argentina)

^c Sanatorio Guemes   (Argentina)

^d HOSPITAL F J MUÑIZ   (Argentina)

^e FLENI   (Argentina)

^f Clinica Bazterrica   (Argentina)

^g NONE   (Argentina)

Author keywords

AIDS; EBV genotypes; HIV; LMP 1; Lymphoma

Indexed keywords

GENOMIC DNA; LATENT MEMBRANE PROTEIN 1; VIRUS DNA; VIRUS RNA;

ADULT; AIDS PATIENT; AMPLICON; ARGENTINA; ARTICLE; BRAIN BIOPSY; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS TYPE 1; EPSTEIN BARR VIRUS TYPE 2; GENE DELETION; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IN SITU HYBRIDIZATION; LMP 1 GENE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; RNA ANALYSIS; SOUTHERN BLOTTING; VIRAL GENETICS; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS STRAIN; VIRUS TYPING;

HUMAN HERPESVIRUS 4;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARGENTINA; BASE SEQUENCE; BIOPSY; BLOTTING, SOUTHERN; BRAIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; EPSTEIN-BARR VIRUS INFECTIONS; GENETIC VARIATION; HERPESVIRUS 4, HUMAN; HIV; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEQUENCE DELETION; SPECIES SPECIFICITY; VIRAL MATRIX PROTEINS;

EID: 33847690221     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20782     Document Type: Article

References (42)

1. Auperin I, Mikolt J, Oksenhendler E, Thiebaut JB, Brunet M, Dupont B, Morinet F. 1994. Primary central nervous system malignant non-Hodgkin's lymphomas from HIV-infected and non-infected patients: Expression of cellular surface proteins and Epstein-Barr viral markers. Neuropathol Appl Neurobiol 20:243-252.
2. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. 1998. EBV persistence in memory B cells in vivo. Immunity 9:395-404.
3. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
4. Berger C, McQuain C, Sullivan JL, Nadal D, Quesenberry PJ, Knecht H. 1997. The 30-bp deletion variant of Epstein-Barr virus-encoded latent membrane protein-1 prevails in acute infectious mononucleosis. J Infect Dis 176:1370-1373.
5. Berger C, van Baarle D, Kersten MJ, Klein MR, Al-Homsi AS, Dunn B, McQuain C, van Oers R, Knecht H. 1999. Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: Reliable markers for individual strain identification. J Infect Dis 179:240-244.
6. Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA. 1991. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 78:3004-3011.
7. Buck M, Cross S, Krauer K, Kienzle N, Sculley TB. 1999. A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle. J Gen Virol 80:441-445.
8. CDC. 1992. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 41:1-19.
9. Chabay P, De Matteo E, Merediz A, Preciado MV. 2004. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina. Arch Virol 149:1515-1526.
10. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS. 1992. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131-2140.
11. Correa RM, Fellner MD, Alonio LV, Durand K, Teyssie AR, Picconi MA. 2004. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene. J Med Virol 73:583-588.
12. Edwards RH, Seillier-Moiseiwitsch F, Raab-Traub N. 1999. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 261:79-95.
13. Fassone L, Cingolani A, Martini M, Migliaretti G, Oreste PL, Capello D, Gloghini A, Vivenza D, Dolcetti R, Carbone A, Antinori A, Gaidano G, Larocca LM. 2002. Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma. AIDS Res Hum Retroviruses 18:19-26.
14. Gratama JW, Ernberg I. 1995. Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res 67:197-255.
15. Gutierrez MI, Kingma DW, Sorbara L, Tran M, Raffeld M, Jaffe ES, Magrath I, Bhatia K. 2000. Association of EBV strains, defined by multiple loci analyses, in non-Hodgkin lymphomas and reactive tissues from HIV positive and HIV negative patients. Leuk Lymphoma 37:425-429.
16. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
17. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G. 1991. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 72:2399-2409.
18. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G. 1993. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8:1575-1583.
19. Kaye KM, Izumi KM, Kieff E. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90:9150-9154.
20. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M. 1996. Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 88:242-251.
21. Knecht H, Bachmann E, Joske DJ, Sahli R, Emery-Goodman A, Casanova JL, Zilic M, Bachmann F, Odermatt BF. 1993. Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia 7:580-585.
22. Knecht H, Raphael M, McQuain C, Rothenberger S, Pihan G, Camilleri-Broet S, Bachmann E, Kershaw GR, Ryan S, Kittler EL, Quesenberry PJ, Schlaifer D, Woda BA, Brousset P. 1996. Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood 87:876-881. Knowles DM. 2003. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin N Am 17:785-820. Hematol Oncol Clin N Am 17:785-820.
23. Li SN, Chang YS, Liu ST. 1996. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 12:2129-2135.
24. Mainou BA, Raab-Traub N. 2006. LMP1 strain variants: Biological and molecular properties. J Virol 80:6458-6468.
25. Maniatis T, Fritsch E, J S. 1989. Molecular cloning: A laboratory manual. New York: J Cold Spring Harbor Laboratory.
26. Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA. 1997. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 71:4882-4891.
27. Neri A, Barriga F, Inghirami G, Knowles DM, Neequaye J, Magrath IT, Dalla-Favera R. 1991. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 77:1092-1095.
28. Rickinson AB, Kieff E. 2001. Epstein Barr Virus. In: Fields BN, Knipe DM, Howley PM, editors. Philadelphia: Lippincott-Raven Press. pp 2575-2627.
29. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
30. Sample J, Hummel M, Braun D, Birkenbach M, E K. 1990. Epstein-Barr Types 1 and 2 differ in their EBNA-3A, EBNA-3B and EBNA-3C genes. J Virol 64:4084-4092.
31. Sandvej K, Peh SC, Andresen BS, Pallesen G. 1994. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84:4053-4060.
32. Santon A, Martin C, Manzanal AI, Preciado MV, Bellas C. 1998. Paediatric Hodgkin's disease in Spain: Association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections. Br J Haematol 103:129-136.
33. Sculley T, Krauer K, Kienzle N. 1999. Comparison of A-type and B-type Epstein Barr virus. Epstein Barr virus report 6:1-6.
34. Srivastava G, Wong KY, Chiang AK, Lam KY, Tao Q. 2000. Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: Reassessment of the viral carrier state. Blood 95:2443-2445.
35. Vallat-Decouvelaere AV, Bretel MA, Vassias I, Laplanche JL, Polivka M, Wassef M, Brunet M, Thiebaut JB, Gosselin B, Morinet F, Mikol J. 2002. High frequency of a 30-bp deletion of Epstein-Barr virus latent membrane protein 1 gene in primary HIV non-Hodgkin's brain lymphomas. Neuropathol Appl Neurobiol 28:471-479.
36. van Baarle D, Hovenkamp E, Kersten MJ, Klein MR, Miedema F, van Oers MH. 1999. Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: No association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 93:3949-3955.
37. van Baarle D, Hovenkamp E, Dukers NH, Renwick N, Kersten MJ, Goudsmit J, Coutinho RA, Miedema F, van Oers MH. 2000. High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission. J Infect Dis 181:2045-2049.
38. Vasef MA, Kamel OW, Chen YY, Medeiros LJ, Weiss LM. 1995. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 147:1408-1415.
39. Wang D, Liebowitz D, Kieff E. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
40. Yao QY, Tierney RJ, Croom-Carter D, Dukers D, Cooper GM, Ellis CJ, Rowe M, Rickinson AB. 1996. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J Virol 70:4884-4894.
41. Yao QY, Croom-Carter DS, Tierney RJ, Habeshaw G, Wilde JT, Hill FG, Conlon C, Rickinson AB. 1998. Epidemiology of infection with Epstein-Barr virus types 1 and 2: Lessons from the study of a T-cell-immunocompromised hemophilic cohort. J Virol 72:4352-4363.
42. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757-768.